Related Experiment Video

Updated: Apr 18, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

859

[miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1]

Xiujuan Li1, Jianhua Zhao, Jinhai Tang2

  • 1Department of General Surgery, Jiangsu Cancer Hospital, Nanjing 210009, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|January 28, 2015
PubMed
Abstract

Insights

MicroRNA-34a (miR-34a) negatively regulates Notch1 expression in breast cancer cells. Increasing miR-34a may enhance the sensitivity of Adriamycin-resistant breast cancer cells to chemotherapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various diseases, including cancer.
  • Notch signaling is a conserved pathway involved in cell differentiation, proliferation, and survival, and its dysregulation is linked to cancer development.
  • Adriamycin (ADR) is a widely used chemotherapy drug, but resistance can limit its efficacy in treating breast cancer.

Purpose of the Study:

  • To investigate the regulatory relationship between miR-34a and Notch1 in breast cancer cells.
  • To determine the impact of miR-34a on the sensitivity of breast cancer cells to Adriamycin (ADR).

Main Methods:

  • Quantitative real-time PCR and Western blot were used to measure miR-34a and Notch1 expression.
  • MCF-7 and MCF-7/ADR cells were transfected with miR-34a mimics or inhibitors.
  • Cell viability (MTT assay) and apoptosis assays were performed to assess ADR sensitivity.
  • Statistical analyses included ANOVA and Spearman rank correlation.

Main Results:

  • miR-34a expression was significantly decreased in Adriamycin-resistant MCF-7/ADR cells compared to sensitive MCF-7 cells.
  • Notch1 mRNA and protein levels were elevated in MCF-7/ADR cells and inversely correlated with miR-34a levels.
  • Overexpression of miR-34a in MCF-7/ADR cells reduced ADR IC50 values and enhanced apoptosis.
  • Inhibition of miR-34a in MCF-7 cells increased ADR IC50 values and reduced apoptosis.

Conclusions:

  • miR-34a acts as a negative regulator of Notch1 expression at both mRNA and protein levels in breast cancer cells.
  • Restoring miR-34a levels can potentially overcome Adriamycin resistance in breast cancer by sensitizing cells to the drug.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.4K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.6K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K